Cargando…
An Optimal Ablative Margin of Small Single Hepatocellular Carcinoma Treated with Image-Guided Percutaneous Thermal Ablation and Local Recurrence Prediction Base on the Ablative Margin: A Multicenter Study
OBJECTIVE: To explore the best ablative margin (AM) for single hepatocellular carcinoma (HCC) patients with image-guided percutaneous thermal ablation (IPTA) based on MRI–MRI fusion imaging, and to develop and validate a local tumor progression (LTP) predictive model based on the recommended AM. MET...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8604653/ https://www.ncbi.nlm.nih.gov/pubmed/34815974 http://dx.doi.org/10.2147/JHC.S330746 |
_version_ | 1784602007444652032 |
---|---|
author | Li, Feng-Yao Li, Jian-Guo Wu, Song-Song Ye, Huo-Lin He, Xu-Qi Zeng, Qing-Jing Zheng, Rong-Qin An, Chao Li, Kai |
author_facet | Li, Feng-Yao Li, Jian-Guo Wu, Song-Song Ye, Huo-Lin He, Xu-Qi Zeng, Qing-Jing Zheng, Rong-Qin An, Chao Li, Kai |
author_sort | Li, Feng-Yao |
collection | PubMed |
description | OBJECTIVE: To explore the best ablative margin (AM) for single hepatocellular carcinoma (HCC) patients with image-guided percutaneous thermal ablation (IPTA) based on MRI–MRI fusion imaging, and to develop and validate a local tumor progression (LTP) predictive model based on the recommended AM. METHODS: Between March 2014 and August 2019, 444 treatment-naïve patients with single HCC (diameter ≤3 cm) who underwent IPTA as first-line treatment from three hospitals were included, which were randomly divided into training (n= 296) and validation (n = 148) cohorts. We measured the ablative margin (AM) by MRI–MRI fusion imaging based on pre-ablation and post-ablation images. Then, we followed up their LPT and verified the optimal AM. Risk factors related to LTP were explored through Cox regression models, the nomogram was developed to predict the LTP risk base on the risk factors, and subsequently validated. The predictive performance and discrimination were assessed and compared with conventional indices. RESULTS: The median follow-up was 19.9 months (95% CI 18.0–21.8) for the entire cohort. The results revealed that the tumor size (HR: 2.16; 95% CI 1.25–3.72; P = 0.003) and AM (HR: 0.72; 95% CI, 0.61–0.85; P < 0.001) were independent prognostic factors for LTP. The AM had a pronounced nonlinear impact on LTP, and a cut-off value of 5-mm was optimal. We developed and validated an LTP predictive model based on the linear tumor size and nonlinear AM. The model showed good predictive accuracy and discrimination (training set, concordance index [C-index] of 0.751; validation set, C-index of 0.756) and outperformed other conventional indices. CONCLUSION: The 5-mm AM is recommended for the best IPTA candidates with single HCC (diameter ≤3 cm). We provided an LTP predictive model that exhibited adequate performance for individualized prediction and risk stratification. |
format | Online Article Text |
id | pubmed-8604653 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-86046532021-11-22 An Optimal Ablative Margin of Small Single Hepatocellular Carcinoma Treated with Image-Guided Percutaneous Thermal Ablation and Local Recurrence Prediction Base on the Ablative Margin: A Multicenter Study Li, Feng-Yao Li, Jian-Guo Wu, Song-Song Ye, Huo-Lin He, Xu-Qi Zeng, Qing-Jing Zheng, Rong-Qin An, Chao Li, Kai J Hepatocell Carcinoma Original Research OBJECTIVE: To explore the best ablative margin (AM) for single hepatocellular carcinoma (HCC) patients with image-guided percutaneous thermal ablation (IPTA) based on MRI–MRI fusion imaging, and to develop and validate a local tumor progression (LTP) predictive model based on the recommended AM. METHODS: Between March 2014 and August 2019, 444 treatment-naïve patients with single HCC (diameter ≤3 cm) who underwent IPTA as first-line treatment from three hospitals were included, which were randomly divided into training (n= 296) and validation (n = 148) cohorts. We measured the ablative margin (AM) by MRI–MRI fusion imaging based on pre-ablation and post-ablation images. Then, we followed up their LPT and verified the optimal AM. Risk factors related to LTP were explored through Cox regression models, the nomogram was developed to predict the LTP risk base on the risk factors, and subsequently validated. The predictive performance and discrimination were assessed and compared with conventional indices. RESULTS: The median follow-up was 19.9 months (95% CI 18.0–21.8) for the entire cohort. The results revealed that the tumor size (HR: 2.16; 95% CI 1.25–3.72; P = 0.003) and AM (HR: 0.72; 95% CI, 0.61–0.85; P < 0.001) were independent prognostic factors for LTP. The AM had a pronounced nonlinear impact on LTP, and a cut-off value of 5-mm was optimal. We developed and validated an LTP predictive model based on the linear tumor size and nonlinear AM. The model showed good predictive accuracy and discrimination (training set, concordance index [C-index] of 0.751; validation set, C-index of 0.756) and outperformed other conventional indices. CONCLUSION: The 5-mm AM is recommended for the best IPTA candidates with single HCC (diameter ≤3 cm). We provided an LTP predictive model that exhibited adequate performance for individualized prediction and risk stratification. Dove 2021-11-15 /pmc/articles/PMC8604653/ /pubmed/34815974 http://dx.doi.org/10.2147/JHC.S330746 Text en © 2021 Li et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Original Research Li, Feng-Yao Li, Jian-Guo Wu, Song-Song Ye, Huo-Lin He, Xu-Qi Zeng, Qing-Jing Zheng, Rong-Qin An, Chao Li, Kai An Optimal Ablative Margin of Small Single Hepatocellular Carcinoma Treated with Image-Guided Percutaneous Thermal Ablation and Local Recurrence Prediction Base on the Ablative Margin: A Multicenter Study |
title | An Optimal Ablative Margin of Small Single Hepatocellular Carcinoma Treated with Image-Guided Percutaneous Thermal Ablation and Local Recurrence Prediction Base on the Ablative Margin: A Multicenter Study |
title_full | An Optimal Ablative Margin of Small Single Hepatocellular Carcinoma Treated with Image-Guided Percutaneous Thermal Ablation and Local Recurrence Prediction Base on the Ablative Margin: A Multicenter Study |
title_fullStr | An Optimal Ablative Margin of Small Single Hepatocellular Carcinoma Treated with Image-Guided Percutaneous Thermal Ablation and Local Recurrence Prediction Base on the Ablative Margin: A Multicenter Study |
title_full_unstemmed | An Optimal Ablative Margin of Small Single Hepatocellular Carcinoma Treated with Image-Guided Percutaneous Thermal Ablation and Local Recurrence Prediction Base on the Ablative Margin: A Multicenter Study |
title_short | An Optimal Ablative Margin of Small Single Hepatocellular Carcinoma Treated with Image-Guided Percutaneous Thermal Ablation and Local Recurrence Prediction Base on the Ablative Margin: A Multicenter Study |
title_sort | optimal ablative margin of small single hepatocellular carcinoma treated with image-guided percutaneous thermal ablation and local recurrence prediction base on the ablative margin: a multicenter study |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8604653/ https://www.ncbi.nlm.nih.gov/pubmed/34815974 http://dx.doi.org/10.2147/JHC.S330746 |
work_keys_str_mv | AT lifengyao anoptimalablativemarginofsmallsinglehepatocellularcarcinomatreatedwithimageguidedpercutaneousthermalablationandlocalrecurrencepredictionbaseontheablativemarginamulticenterstudy AT lijianguo anoptimalablativemarginofsmallsinglehepatocellularcarcinomatreatedwithimageguidedpercutaneousthermalablationandlocalrecurrencepredictionbaseontheablativemarginamulticenterstudy AT wusongsong anoptimalablativemarginofsmallsinglehepatocellularcarcinomatreatedwithimageguidedpercutaneousthermalablationandlocalrecurrencepredictionbaseontheablativemarginamulticenterstudy AT yehuolin anoptimalablativemarginofsmallsinglehepatocellularcarcinomatreatedwithimageguidedpercutaneousthermalablationandlocalrecurrencepredictionbaseontheablativemarginamulticenterstudy AT hexuqi anoptimalablativemarginofsmallsinglehepatocellularcarcinomatreatedwithimageguidedpercutaneousthermalablationandlocalrecurrencepredictionbaseontheablativemarginamulticenterstudy AT zengqingjing anoptimalablativemarginofsmallsinglehepatocellularcarcinomatreatedwithimageguidedpercutaneousthermalablationandlocalrecurrencepredictionbaseontheablativemarginamulticenterstudy AT zhengrongqin anoptimalablativemarginofsmallsinglehepatocellularcarcinomatreatedwithimageguidedpercutaneousthermalablationandlocalrecurrencepredictionbaseontheablativemarginamulticenterstudy AT anchao anoptimalablativemarginofsmallsinglehepatocellularcarcinomatreatedwithimageguidedpercutaneousthermalablationandlocalrecurrencepredictionbaseontheablativemarginamulticenterstudy AT likai anoptimalablativemarginofsmallsinglehepatocellularcarcinomatreatedwithimageguidedpercutaneousthermalablationandlocalrecurrencepredictionbaseontheablativemarginamulticenterstudy AT lifengyao optimalablativemarginofsmallsinglehepatocellularcarcinomatreatedwithimageguidedpercutaneousthermalablationandlocalrecurrencepredictionbaseontheablativemarginamulticenterstudy AT lijianguo optimalablativemarginofsmallsinglehepatocellularcarcinomatreatedwithimageguidedpercutaneousthermalablationandlocalrecurrencepredictionbaseontheablativemarginamulticenterstudy AT wusongsong optimalablativemarginofsmallsinglehepatocellularcarcinomatreatedwithimageguidedpercutaneousthermalablationandlocalrecurrencepredictionbaseontheablativemarginamulticenterstudy AT yehuolin optimalablativemarginofsmallsinglehepatocellularcarcinomatreatedwithimageguidedpercutaneousthermalablationandlocalrecurrencepredictionbaseontheablativemarginamulticenterstudy AT hexuqi optimalablativemarginofsmallsinglehepatocellularcarcinomatreatedwithimageguidedpercutaneousthermalablationandlocalrecurrencepredictionbaseontheablativemarginamulticenterstudy AT zengqingjing optimalablativemarginofsmallsinglehepatocellularcarcinomatreatedwithimageguidedpercutaneousthermalablationandlocalrecurrencepredictionbaseontheablativemarginamulticenterstudy AT zhengrongqin optimalablativemarginofsmallsinglehepatocellularcarcinomatreatedwithimageguidedpercutaneousthermalablationandlocalrecurrencepredictionbaseontheablativemarginamulticenterstudy AT anchao optimalablativemarginofsmallsinglehepatocellularcarcinomatreatedwithimageguidedpercutaneousthermalablationandlocalrecurrencepredictionbaseontheablativemarginamulticenterstudy AT likai optimalablativemarginofsmallsinglehepatocellularcarcinomatreatedwithimageguidedpercutaneousthermalablationandlocalrecurrencepredictionbaseontheablativemarginamulticenterstudy |